欧洲神经毒素市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品类型(Botox、Dysport、Xenomin 等)、应用(治疗和美容)和最终用户(医院、专科诊所、皮肤科诊所等) )

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2028


No. of Pages: 119    |    Report Code: BMIRE00028618    |    Category: Life Sciences

Europe Neurotoxins Market

欧洲神经毒素市场预计将从 2023 年的 11.7494 亿美元增长到 2028 年的 20.3894 亿美元。预计 2022 年至 2028 年复合年增长率为 11.7%。

改善外观的整容手术激增推动欧洲神经毒素市场

结构变化影响由于细胞功能随着年龄的增长而下降,皮肤、肌肉、韧带、脂肪和骨骼在人的脸上变得很明显。许多人通常不积极地看待衰老这一不可避免的生理过程,这反过来又促使他们沉迷于美容年轻化手术,以在视觉上保持年轻。肉毒杆菌毒素 (BOTA) 是整容手术中最常用的神经毒素。治疗上述病例的 BOTA 选择涉及含有 500 个欧洲单位的 Abobotulinum A(ABO;Dysport/Ipsen Limited,斯劳伯克郡,英国)。按照制造商推荐的2.5ml盐水溶液与500单位肉毒毒素的施用比例,进行重构。因此,涉及神经毒素的整容手术越来越受欢迎,以减少面部皱纹,同时确保安全性、有效性和效率,这正在促进神经毒素市场的发展。

欧洲神经毒素市场概述

欧洲神经毒素市场已细分为英国、德国、法国、意大利、西班牙、波兰、俄罗斯和欧洲其他地区。老年人口的激增、产品推出的增加、神经毒素产品分销的增加以及政府对非手术美容产品和程序的监管不断加强可能会促进市场增长。此外,美容诊所数量的增加可能为市场增长提供重要的增长机会。在英国,没有行业来规范非手术程序的标准。此外,进行肉毒杆菌或填充剂注射程序不需要法律许可。因此,这些是过去几年全国神经毒素市场增长的主要因素。然而,2013 年,英国健康教育局针对从业者未能改善公共保护并降低可能导致美容手术严重副作用的风险制定了标准和资格框架。

< strong>欧洲神经毒素市场收入及预测至 2028 年(百万美元)

< p>

欧洲神经毒素市场细分

欧洲神经毒素市场分为产品类型、应用、最终用户和国家。< /span>

根据产品类型,欧洲神经毒素市场分为肉毒杆菌、dysport、xenomin 等。肉毒杆菌细分市场在 2023 年占据最大的市场份额。

根据应用,欧洲神经毒素市场分为治疗和美容。到2023年,治疗领域将占据更大的市场份额。

根据最终用户,市场分为医院、专科诊所、皮肤科诊所等。 2023 年,医院细分市场占据最大的市场份额。

根据国家/地区,市场分为英国、德国、法国、意大利、西班牙、波兰、俄罗斯,以及欧洲其他地区。德国在 2023 年占据市场份额。

AbbVie Inc、Evolus Inc、Hugel Inc、Ipsen SA、Meditox Inc 和 Merz Pharma GmbH & Co KGaA 是欧洲神经毒素市场的领先公司之一。  



Europe Neurotoxins Strategic Insights

Strategic insights for Europe Neurotoxins involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-neurotoxins-market-strategic-framework.webp
Get more information on this report

Europe Neurotoxins Report Scope

Report Attribute Details
Market size in 2023 US$ 1,174.94 Million
Market Size by 2028 US$ 2,038.94 Million
Global CAGR (2022 - 2028) 11.7%
Historical Data 2021-2022
Forecast period 2024-2028
Segments Covered By 产品类型
  • Botox
  • Dysport
  • Xenomin
By 应用
  • 治疗和美容
By 最终用户
  • 医院
  • 专科诊所
  • 皮肤科诊所
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • AbbVie Inc
  • Evolus Inc
  • Hugel Inc
  • Ipsen SA
  • Medytox Inc
  • Merz Pharma GmbH & Co KGaA
  • Get more information on this report

    Europe Neurotoxins Regional Insights

    The regional scope of Europe Neurotoxins refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-neurotoxins-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Neurotoxins Market

    1. AbbVie Inc
    2. Evolus Inc
    3. Hugel Inc
    4. Ipsen SA
    5. Medytox Inc
    6. Merz Pharma GmbH & Co KGaA
    Frequently Asked Questions
    How big is the Europe Neurotoxins Market?

    The Europe Neurotoxins Market is valued at US$ 1,174.94 Million in 2023, it is projected to reach US$ 2,038.94 Million by 2028.

    What is the CAGR for Europe Neurotoxins Market by (2022 - 2028)?

    As per our report Europe Neurotoxins Market, the market size is valued at US$ 1,174.94 Million in 2023, projecting it to reach US$ 2,038.94 Million by 2028. This translates to a CAGR of approximately 11.7% during the forecast period.

    What segments are covered in this report?

    The Europe Neurotoxins Market report typically cover these key segments-

  • 产品类型 (Botox, Dysport, Xenomin)
  • 应用 (治疗和美容)
  • 最终用户 (医院, 专科诊所, 皮肤科诊所)
  • What is the historic period, base year, and forecast period taken for Europe Neurotoxins Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Neurotoxins Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2028
  • Who are the major players in Europe Neurotoxins Market?

    The Europe Neurotoxins Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • AbbVie Inc
  • Evolus Inc
  • Hugel Inc
  • Ipsen SA
  • Medytox Inc
  • Merz Pharma GmbH & Co KGaA
  • Who should buy this report?

    The Europe Neurotoxins Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Neurotoxins Market value chain can benefit from the information contained in a comprehensive market report.